RET and medullary thyroid gland carcinoma: MTC, which is caused by dominant activating mutations in the RET proto-oncogene encoding a transmembrane tyrosine kinase receptor, is characterized by aggressive growth and early metastasis and, therefore, provides a perfect model for targeting disseminated cancer cells [69].